about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

FAculty directory

Back to alphabetical index

Dr. Thomas Fekete


Thomas Fekete, MD


Section Chief, Infectious Diseases

Professor, Medicine

Associate Professor, Microbiology and Immunology

Executive Vice Chair for Clinical Affairs, Department of Medicine

Telephone:  215-707-3807

FAX: 215-707-4414

Email: tomfeke@temple.edu


Department of Medicine, Section of Infectious Diseases

Department of Microbiology and Immunology


Educational Background:


AB, Princeton University


MD, Tufts University School of Medicine


Medicine Residency, Rush-Presbyterian-St. Luke's


Fellowship in Infectious Diseases and Clinical Pharmacology, University of Chicago


Return to top



clinical Interests:


  • History and status of anti-infective efficacy and resistance
  • Enzymatic and other mechanisms of resistance
  • Epidemiology of resistance patterns

Return to top



professional Societies:


  • Fellow, American College of Physicians
  • Fellow, Infectious Diseases Society of America
  • Member, American Association for the Advancement of Science
  • Member, American Society for Microbiology
  • Fellow, College of Physicians of Philadelphia
  • Alpha Omega Alpha Honor Society

Return to top





  • Internal medicine
  • Infectious diseases
  • Microbiology

Return to top



Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

26132142. Momplaisir FM, Brady KA, Fekete T, Thompson DR, Diez Roux A, Yehia BR, Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV. PLoS One 10:7(e0132262)2015

24288844. Fekete T, Who killed lab rounds? Pharos Alpha Omega Alpha Honor Med Soc 76:4(32-4)2013 Autumn

23689777. Fekete T, ACP Journal Club. Review: probiotics reduce Clostridium difficile-associated diarrhea in patients receiving antibiotics. Ann Intern Med 158:10(JC10)2013 May 21

21835501. Baang JH, Axelrod P, Decker BK, Hujer AM, Dash G, Truant AR, Bonomo RA, Fekete T, Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital. Am J Infect Control 40:2(134-7)2012 Mar

21615067. Lorber B, Fekete T, Community-acquired pneumonia. The tyranny of a term. Pharos Alpha Omega Alpha Honor Med Soc 74:2(19-21)2011 Spring

20956696. Fekete T, ACP Journal Club. Concurrent PPIs and antibiotics for incident C. difficile infection were associated with increased risk for recurrent infection. Ann Intern Med 153:8(JC4-12)2010 Oct 19

20547899. Fekete T, ACP Journal Club. Pneumococcal vaccine reduced pneumococcal pneumonia and associated mortality. Ann Intern Med 152:12(JC6-5)2010 Jun 15

18799698. Kosmin AR, Fekete T, Use of fungal blood cultures in an academic medical center. J Clin Microbiol 46:11(3800-1)2008 Nov

18515627. Fekete T, 5 days of nitrofurantoin was equivalent to 3 days of trimethoprim-sulfamethoxazole for women with non-complicated cystitis. Evid Based Med 13:3(80)2008 Jun

17634309. Bofinger JJ, Fekete T, Samuel R, Bacterial peritonitis caused by Kingella kingae. J Clin Microbiol 45:9(3118-20)2007 Sep

17461996. Monkowski DH, Axelrod P, Fekete T, Hollander T, Furukawa S, Samuel R, Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis 9:2(114-20)2007 Jun

16877101. Bettiker RL, Axelrod PI, Fekete T, St John K, Truant A, Toney S, Yakrus MA, Delayed recognition of a pseudo-outbreak of Mycobacterium terrae. Am J Infect Control 34:6(343-7)2006 Aug

16490338. Ooi ST, Fekete T, Causes of and clinical sequelae of delays in reporting species identification of mycobacteria other than Mycobacterium tuberculosis and Mycobacterium avium complex. Diagn Microbiol Infect Dis 55:1(69-73)2006 May

16262218. Fekete T, A varicella-zoster virus vaccine reduced the burden of illness of herpes zoster in older adults. ACP J Club 143:3(61)2005 Nov-Dec

15728934. Levin TP, Suh B, Axelrod P, Truant AL, Fekete T, Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother 49:3(1222-4)2005 Mar

15365048. Levin TP, Baty DE, Fekete T, Truant AL, Suh B, Cladophialophora bantiana brain abscess in a solid-organ transplant recipient: case report and review of the literature. J Clin Microbiol 42:9(4374-8)2004 Sep

12418852. Fekete T, Ultrasonography plus radiography was as effective as intravenous urography for detecting abnormalities in men with proven UTI. ACP J Club 137:3(112)2002 Nov-Dec

12138976. Samuel R, Axelrod P, John KS, Fekete T, Alexander S, McCarthy J, Truant A, Todd B, Furukawa S, Eisen H, Spotnitz W, An outbreak of mediastinitis among heart transplant recipients apparently related to a change in the united network for organ sharing guidelines. Infect Control Hosp Epidemiol 23:7(377-81)2002 Jul

8678093. Fekete T, Tumah H, Woodwell J, Satishchandran V, Truant A, Axelrod P, Comparative susceptibilities of Klebsiella species, Enterobacter species, and Pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary-care university hospital. Am J Med 100:6A(20S-25S)1996 Jun 24

8718611. Tumah H, Woodwell J, Chatwani A, Truant A, Fekete T, Patterns of resistance in organisms causing gynecologic infections. Adv Exp Med Biol 390:(169-75)1995

7746716. Fekete T, Bacterial genetics, antibiotic usage, and public policy: the crucial interplay in emerging resistance. Perspect Biol Med 38:3(363-82)1995 Spring

7844336. Forman W, Axelrod P, St John K, Kostman J, Khater C, Woodwell J, Vitagliano R, Truant A, Satishchandran V, Fekete T, Investigation of a pseudo-outbreak of orthopedic infections caused by Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 15:10(652-7)1994 Oct

7924222. Fekete T, Tumah H, Woodwell J, Truant A, Satishchandran V, Axelrod P, Kreter B, A comparison of serial plate agar dilution, Bauer-Kirby disk diffusion, and the Vitek AutoMicrobic system for the determination of susceptibilities of Klebsiella spp., Enterobacter spp., and Pseudomonas aeruginosa to ten antimicrobial agents. Diagn Microbiol Infect Dis 18:4(251-8)1994 Apr

8457978. Fekete T, Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy. Clin Microbiol Rev 6:1(22-33)1993 Jan

2041953. Kostman JR, Solomon F, Fekete T, Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients. Rev Infect Dis 13:2(233-6)1991 Mar-Apr

1903910. Fekete T, Woodwell J, Cundy KR, Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters. Antimicrob Agents Chemother 35:3(497-9)1991 Mar

2136838. Fekete T, Controversies in the prevention of infective endocarditis related to dental procedures. Dent Clin North Am 34:1(79-90)1990 Jan

2497703. Fekete T, Serfass DA, Lafredo SC, Cundy KR, Susceptibility to cephalosporins of penicillin-susceptible and penicillin-resistant strains of Neisseria gonorrhoeae from Philadelphia. Antimicrob Agents Chemother 33:2(164-6)1989 Feb

3341865. Braun TI, Fekete T, Lynch A, Strongyloidiasis in an institution for mentally retarded adults. Arch Intern Med 148:3(634-6)1988 Mar

Return to top